99 related articles for article (PubMed ID: 9657426)
1. Post-translational modifications required for coagulation factor secretion and function.
Kaufman RJ
Thromb Haemost; 1998 Jun; 79(6):1068-79. PubMed ID: 9657426
[No Abstract] [Full Text] [Related]
2. Regulation of tissue factor procoagulant activity by post-translational modifications.
Egorina EM; Sovershaev MA; Osterud B
Thromb Res; 2008; 122(6):831-7. PubMed ID: 18191444
[TBL] [Abstract][Full Text] [Related]
3. Prediction of human protein function from post-translational modifications and localization features.
Jensen LJ; Gupta R; Blom N; Devos D; Tamames J; Kesmir C; Nielsen H; Staerfeldt HH; Rapacki K; Workman C; Andersen CA; Knudsen S; Krogh A; Valencia A; Brunak S
J Mol Biol; 2002 Jun; 319(5):1257-65. PubMed ID: 12079362
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation and glycosylation interplay: protein modifications at hydroxy amino acids and prediction of signaling functions of the human beta3 integrin family.
Ahmad I; Hoessli DC; Walker-Nasir E; Choudhary MI; Rafik SM; Shakoori AR;
J Cell Biochem; 2006 Oct; 99(3):706-18. PubMed ID: 16676352
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of factor IX: implications for gene therapy.
Furie BC; Furie B
Thromb Haemost; 1995 Jul; 74(1):274-7. PubMed ID: 8578471
[No Abstract] [Full Text] [Related]
6. MAPRes: Mining association patterns among preferred amino acid residues in the vicinity of amino acids targeted for post-translational modifications.
Ahmad I; Qazi WM; Khurshid A; Ahmad M; Hoessli DC; Khawaja I; Choudhary MI; Shakoori AR;
Proteomics; 2008 May; 8(10):1954-8. PubMed ID: 18491291
[TBL] [Abstract][Full Text] [Related]
7. Post-translational modifications in proteins involved in blood coagulation.
Hansson K; Stenflo J
J Thromb Haemost; 2005 Dec; 3(12):2633-48. PubMed ID: 16129023
[No Abstract] [Full Text] [Related]
8. Post-translational modifications of the AFET3 gene product: a component of the iron transport system in budding cells and mycelia of the yeast Arxula adeninivorans.
Wartmann T; Stephan UW; Bube I; Böer E; Melzer M; Manteuffel R; Stoltenburg R; Guengerich L; Gellissen G; Kunze G
Yeast; 2002 Jul; 19(10):849-62. PubMed ID: 12112239
[TBL] [Abstract][Full Text] [Related]
9. In silico determination of intracellular glycosylation and phosphorylation sites in human selectins: implications for biological function.
Ahmad I; Hoessli DC; Gupta R; Walker-Nasir E; Rafik SM; Choudhary MI; Shakoori AR;
J Cell Biochem; 2007 Apr; 100(6):1558-72. PubMed ID: 17230456
[TBL] [Abstract][Full Text] [Related]
10. Processing, secretion, and anti-HIV-1 activity of IL-16 with or without a signal peptide in CD4+ T cells.
Zhou P; Devadas K; Tewari D; Jegorow A; Notkins AL
J Immunol; 1999 Jul; 163(2):906-12. PubMed ID: 10395686
[TBL] [Abstract][Full Text] [Related]
11. Structural requirements of a human deoxyribonuclease II for the development of the active enzyme form, revealed by site-directed mutagenesis.
Yasuda T; Takeshita H; Iida R; Nakajima T; Hosomi O; Nakashima Y; Mori S; Kishi K
Biochem Biophys Res Commun; 1999 Mar; 256(3):591-4. PubMed ID: 10080942
[TBL] [Abstract][Full Text] [Related]
12. MAPRes: an efficient method to analyze protein sequence around post-translational modification sites.
Ahmad I; Hoessli DC; Qazi WM; Khurshid A; Mehmood A; Walker-Nasir E; Ahmad M; Shakoori AR;
J Cell Biochem; 2008 Jul; 104(4):1220-31. PubMed ID: 18286469
[TBL] [Abstract][Full Text] [Related]
13. Rerouting of fibroblast growth factor 2 to the classical secretory pathway results in post-translational modifications that block binding to heparan sulfate proteoglycans.
Wegehingel S; Zehe C; Nickel W
FEBS Lett; 2008 Jul; 582(16):2387-92. PubMed ID: 18538671
[TBL] [Abstract][Full Text] [Related]
14. Multiple post-translational modifications of mouse insulin-like growth factor binding protein-6 expressed in epithelial Madin-Darby canine kidney cells.
Shalamanova L; Kübler B; Storch S; Scharf JG; Braulke T
Mol Cell Endocrinol; 2008 Nov; 295(1-2):18-23. PubMed ID: 18824213
[TBL] [Abstract][Full Text] [Related]
15. The endothelial cell protein C receptor: a candidate genetic risk factor for thrombosis.
Simmonds RE; Lane DA
Thromb Haemost; 2001 Oct; 86(4):939-41. PubMed ID: 11686348
[No Abstract] [Full Text] [Related]
16. Post-translational modifications influence transcription factor activity: a view from the ETS superfamily.
Tootle TL; Rebay I
Bioessays; 2005 Mar; 27(3):285-98. PubMed ID: 15714552
[TBL] [Abstract][Full Text] [Related]
17. C-terminal proteolysis of prenylated proteins in trypanosomatids and RNA interference of enzymes required for the post-translational processing pathway of farnesylated proteins.
Gillespie JR; Yokoyama K; Lu K; Eastman RT; Bollinger JG; Van Voorhis WC; Gelb MH; Buckner FS
Mol Biochem Parasitol; 2007 Jun; 153(2):115-24. PubMed ID: 17397944
[TBL] [Abstract][Full Text] [Related]
18. Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR).
Wu SL; Kim J; Hancock WS; Karger B
J Proteome Res; 2005; 4(4):1155-70. PubMed ID: 16083266
[TBL] [Abstract][Full Text] [Related]
19. Surface accessibility of protein post-translational modifications.
Pang CN; Hayen A; Wilkins MR
J Proteome Res; 2007 May; 6(5):1833-45. PubMed ID: 17428077
[TBL] [Abstract][Full Text] [Related]
20. Regulation of proliferation-survival decisions is controlled by FGF1 secretion in retinal pigmented epithelial cells.
Bryckaert M; Guillonneau X; Hecquet C; Perani P; Courtois Y; Mascarelli F
Oncogene; 2000 Oct; 19(42):4917-29. PubMed ID: 11039909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
